Please login to the form below
4D Molecular Therapeutics
This page shows the latest 4D Molecular Therapeutics news and features for those working in and with pharma, biotech and healthcare.
AZ makes gene therapy move with 4DMT alliance
AstraZeneca’s push into genetic therapies has stepped up a gear, thanks to a collaboration with 4D Molecular Therapeutics on a new project in chronic lung disease.
Latest news
-
Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and more
The company has today announced an expanded partnership with Emeryville, California-based 4D Molecular Therapeutics (4DMT), which specialises in adeno-associated virus (AAV) gene therapy vector discovery and product development. ... 4DMT’s
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Health Consultant - Brand Comms
-
Competitive Salary
- Senior Account Manager, Medical Communications, London
-
Excellent package
-
Digital Account Director
-
Salary TBC
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Freelance Senior Account Manager / Account Director - Healthcare...
-
£350-400 depending on experience
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Freelance AM/ AD Healthcare Advertising
-
£350-400 depending on experience
-
Senior Medical Writer
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Scientific Director – Medical Communications
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Where next in Alzheimer’s disease R&D?
- McCann Health bolsters European leadership team
- Biogen and Eisai pull plug on Alzheimer’s drug
- Novo uses voucher for speedy answer on oral semaglutide
- Is Orkambi deal close? Vertex meets again today with NHS England
- Amgen, Servier heart failure drug clears trial hurdle
PMHub
Consulting at McCann Health
We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...
Latest intelligence
- Where next in Alzheimer’s disease R&D?
- How past failures and emerging biology are reshaping drug development...
- Brain power: fresh approaches to Alzheimer’s drug discovery
- New alliances are learning from past mistakes and breaking down research barriers...
- Genomics integration: can the NHS rise to the challenge?
- Experts gather to discuss the UK’s genomic landscape...
Quick links
Infographics
